Prestige Consumer Healthcare to Release Fiscal 2026 Second Quarter Earnings Results
Prestige Consumer Healthcare (NYSE:PBH) will release its fiscal 2026 second quarter and first half earnings on Thursday, November 6, 2025 before market open. The company will host a conference call the same morning at 8:30 a.m. ET to discuss results.
Investors can join a live webcast from the Investor Relations page at www.prestigeconsumerhealthcare.com or register to receive dial-in details and a unique PIN for phone participation. A replay of the call will be available on the Investor Relations page for approximately one week after the live event.
Prestige Consumer Healthcare (NYSE:PBH) pubblicherà i ricavi del secondo trimestre e della prima metà dell’esercizio 2026 il giovedì 6 novembre 2025 prima dell’apertura del mercato. L’azienda terrà una conference call nella stessa mattinata alle 8:30 a.m. ET per discutere i risultati.
Gli investitori possono partecipare a una trasmissione in diretta dalla pagina Investor Relations all’indirizzo www.prestigeconsumerhealthcare.com oppure registrarsi per ricevere i dettagli di dial-in e un PIN univoco per la partecipazione telefonica. Una replica della chiamata sarà disponibile sulla pagina Investor Relations per circa una settimana dopo l’evento in diretta.
Prestige Consumer Healthcare (NYSE:PBH) publicará sus ingresos del segundo trimestre y del primer semestre fiscales de 2026 el jueves 6 de noviembre de 2025 antes de la apertura del mercado. La empresa organizará una conferencia telefónica esa misma mañana a las 8:30 a.m. ET para discutir los resultados.
Los inversores pueden unirse a una transmisión en vivo desde la página de Relaciones con Inversores en www.prestigeconsumerhealthcare.com o registrarse para recibir los detalles de marcación y un PIN único para la participación por teléfono. Una reproducción de la llamada estará disponible en la página de Relaciones con Inversores durante aproximadamente una semana después del evento en vivo.
Prestige Consumer Healthcare (NYSE:PBH)는 2026 회계연도 제2분기 및 상반기 실적을 2025년 11월 6일 목요일 시장 개장 전 발표합니다. 같은 아침 8:30 a.m. ET에 결과를 논의하기 위한 컨퍼런스 콜을 개최합니다.
투자자들은 www.prestigeconsumerhealthcare.com의 Investor Relations 페이지에서 라이브 웹캐스트에 참여하거나 전화 참여를 위한 다이얼 인 상세 정보와 고유 PIN을 받도록 등록할 수 있습니다. 라이브 이벤트 후 약 1주일간 Investor Relations 페이지에서 콜의 재생을 이용할 수 있습니다.
Prestige Consumer Healthcare (NYSE:PBH) publiera ses résultats du deuxième trimestre et de la première moitié de l’exercice 2026 le jeudi 6 novembre 2025 avant l’ouverture des marchés. L’entreprise organisera la même matinée une conférence téléphonique à 8 h 30, heure de l’Est (ET) pour discuter des résultats.
Les investisseurs peuvent rejoindre une diffusion en direct depuis la page Investor Relations sur www.prestigeconsumerhealthcare.com ou s’inscrire pour recevoir les détails d’accès et un code PIN unique pour la participation téléphonique. Une rediffusion de l’appel sera disponible sur la page Investor Relations pendant environ une semaine après l’événement en direct.
Prestige Consumer Healthcare (NYSE:PBH) wird seine Ergebnisse für das zweite Quartal und das erste Halbjahr des Geschäftsjahres 2026 am Donnerstag, den 6. November 2025 vor Börseneröffnung veröffentlichen. Das Unternehmen wird am selben Morgen um 8:30 Uhr Eastern Time (ET) eine Telefonkonferenz abhalten, um die Ergebnisse zu erläutern.
Investoren können über die Investor Relations-Seite unter www.prestigeconsumerhealthcare.com an einem Live-Webcast teilnehmen oder sich registrieren, um Dial-in-Details und eine eindeutige PIN für die telefonische Teilnahme zu erhalten. Eine Wiederholung der Konferenz wird nach dem Live-Ereignis auf der Investor Relations-Seite etwa eine Woche lang verfügbar sein.
Prestige Consumer Healthcare (NYSE:PBH) ستصدر أرباح الربعين الثالث والرابع من السنة المالية 2026 في الخميس 6 نوفمبر 2025 قبل افتـتاح السوق. ستعقد الشركة مكالمة هاتفية في الصباح نفسه عند الساعة 8:30 صباحاً بتوقيت شرق الولايات المتحدة (ET) لمناقشة النتائج.
يمكن للمستثمرين الانضمام إلى البث المباشر من صفحة علاقات المستثمرين على www.prestigeconsumerhealthcare.com أو التسجيل لاستلام تفاصيل الاتصال ورقم تعريف شخصي فريد للمشاركة عبر الهاتف. سيكون هناك إعادة تشغيل للمكالمة على صفحة علاقات المستثمرين لمدة حوالي أسبوع بعد الحدث المباشر.
Prestige Consumer Healthcare (NYSE:PBH) 将在 2025 年 11 月 6 日星期四 美国东部时间开市前公布 2026 财政年度第二季度及上半年的业绩。公司将于同日早上 8:30 a.m. ET 举行电话会议以讨论业绩。
投资者可通过 www.prestigeconsumerhealthcare.com 的投资者关系页面收看现场网络广播，或注册以获取拨入信息和用于电话参与的唯一 PIN。电话会议的重播将在现场活动结束后大约一周内在投资者关系页面提供。
- None.
- None.
TARRYTOWN, N.Y., Oct. 06, 2025 (GLOBE NEWSWIRE) -- Prestige Consumer Healthcare Inc. (NYSE:PBH) today announced that it will issue its fiscal 2026 second quarter and first half earnings release on Thursday, November 6, 2025 before the opening of the market. The Company will host a conference call to discuss the results that same morning at 8:30 a.m. ET.
To participate in the live Internet webcast of the conference call, it can be accessed from the Investor Relations page of www.prestigeconsumerhealthcare.com. To participate in the conference call via phone, participants may register for the call here to receive dial-in details and a unique pin. While not required, it is recommended to join 10 minutes prior to the event start.
A conference call replay will be available for approximately one week following completion of the live call and can be accessed on the Company’s Investor Relations page.
About Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare markets, sells, manufactures and distributes consumer healthcare products to retail outlets throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s diverse portfolio of brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® and TheraTears® eye care products, DenTek® specialty oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® and Luden's® sore throat treatments and drops, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Boudreaux’s Butt Paste® diaper rash ointments, Nix® lice treatment, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia. Visit the Company's website at www.prestigeconsumerhealthcare.com.
Investor Relations Contact Phil Terpolilli, CFA, 914-524-6819 irinquiries@prestigebrands.com
FAQ
When will Prestige Consumer Healthcare (PBH) release fiscal 2026 Q2 results?
What time is the PBH earnings conference call on November 6, 2025?
How can investors access the PBH November 6, 2025 webcast?
How do I join the PBH conference call by phone?
Will there be a replay of the PBH November 6, 2025 earnings call?
